Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-10-21Connectedness as a mechanism of change in psilocybin-assisted cognitive behavioral therapy for major depressive disorderPsychedelics · 2026-10-14Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use DisordersCurrent Addiction Reports · 2026-09-02Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-21Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-14A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress DisorderCurrent Treatment Options in Psychiatry · 2025-12-25A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderClinicalTrials.gov · 2025-08-19Psilocybin's lasting action requires pyramidal cell types and 5-HT receptors.Nature · 2025-06-01ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-24Undergraduate Students' Perceptions and Understanding of Psychedelic-Assisted TherapyExhibit - A Showcase of Scholarship, Creativity and Preservation Provided by Xavier University Library (Xavier University) · 2025-04-23PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and BehaviourbioRxiv · 2025-04-14Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.Journal of affective disorders · 2025-02-01Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.Journal of psychoactive drugs · 2025-01-01Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.Nature. Mental health · 2024-11-01Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.Npj mental health research · 2024-10-06Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.Physiology & behavior · 2024-10-01Stutterers' experiences on classic psychedelics: A preliminary self-report study.Journal of fluency disorders · 2024-09-01Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.Scientific reports · 2024-02-07Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Psychedelics: Threshold of a Therapeutic Revolution.Neuropharmacology · 2023-09-15Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.Neuropharmacology · 2023-08-01Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.Journal of psychopharmacology (Oxford, England) · 2023-01-01Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report.Frontiers in psychiatry · 2023-01-01Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.Neuropharmacology · 2022-11-15Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Neuropharmacology · 2022-11-01Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviourNeuroscience Applied · 2022-01-01Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.Current topics in behavioral neurosciences · 2022-01-01A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic HealingJournal of Humanistic Psychology · 2021-09-16The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.Neuropharmacology · 2018-11-01The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Journal of affective disorders · 2018-04-01Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.Psychopharmacology · 2018-02-01Iconography in Bradshaw rock art: breaking the circularity.Clinical & experimental optometry · 2011-09-01What geometric visual hallucinations tell us about the visual cortex.Neural computation · 2002-03-01Theoretical studies on the conformations of psilocin and mescaline.Molecular pharmacology · 1973-09-01